Efficacy and safety of cilostazol based triple antiplatelet treatment versus dual antiplatelet treatment in patients undergoing coronary stent implantation: an updated meta-analysis of the randomized controlled trials
- 29 May 2014
- journal article
- research article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 39 (1) , 23-34
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Cilostazol added to aspirin and clopidogrel reduces revascularization without increases in major adverse events in patients with drug-eluting stents: A meta-analysis of randomized controlled trialsInternational Journal of Cardiology, 2013
- Efficacy and Safety of Triple Antiplatelet Therapy in Obese Patients Undergoing Stent ImplantationAngiology, 2013
- Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary StentingNew England Journal of Medicine, 2012
- Meta-Analysis of Randomized Controlled Trials on Effect of Cilostazol on Restenosis Rates and Outcomes After Percutaneous Coronary InterventionThe American Journal of Cardiology, 2012
- Role of Endothelial Shear Stress in Stent Restenosis and ThrombosisJACC, 2012
- Adding Cilostazol to Dual Antiplatelet Therapy Achieves Greater Platelet Inhibition than High Maintenance Dose Clopidogrel in Patients With Acute Myocardial InfarctionCirculation: Cardiovascular Interventions, 2010
- Comparison of Triple Antiplatelet Therapy and Dual Antiplatelet Therapy in Patients at High Risk of Restenosis After Drug–Eluting Stent Implantation (from the DECLARE-DIABETES and -LONG Trials)The American Journal of Cardiology, 2010
- Triple antiplatelet therapy vs. dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: an evidence‐based approach to answering a clinical queryBritish Journal of Clinical Pharmacology, 2009
- Effects of Triple Antiplatelet Therapy (Aspirin, Clopidogrel, and Cilostazol) on Platelet Aggregation and P-Selectin Expression in Patients Undergoing Coronary Artery Stent ImplantationThe American Journal of Cardiology, 2007
- Cilostazol inhibits leukocyte integrin Mac-1, leading to a potential reduction in restenosis after coronary stent implantationJACC, 2004